
Dr. James M. Brinkworth
- Gender: Male
- Experience: 43 years
- Sole propriator: No
- NPI: 1548296254
Dr. James M. Brinkworth MD
Pathologist
He is located at 1000 North Lee Avenue in Oklahoma City, OK 73102. Can help patients with the following: Benign Tumor, Cyst, Infarction, Skin Biopsy. His National Provider Identifier (NPI) number is 1548296254. Appointment can be made via the phone number (405) 272-7041.
Conditions treated
Dr. James Brinkworth, being an pathologist, treats the following conditions. Please be advised that this list may not be complete. For the full list of conditions treated, consult directly with Dr. James M. Brinkworth.
- Benign Tumor
- Cyst
- Infarction
- Skin Biopsy
Procedures Performed by Dr. James M. Brinkworth
Insurances Accepted by Dr. James M. Brinkworth
- Medicare
Payments received
Drug payment
St. Jude Medical | $180 |
Abbott Laboratories | $118 |
Amgen | $101 |
Other
Food and Beverage | $964 |
Looking for more Pathologists?
- Gender: Female
- Address: 101 The City Drive South Orange, 92868, CA
- Gender: Female
- Address: 820 North Chelan Avenue Wenatchee, 98801, WA
- Gender: Female
- Address: 3500 Gaston Avenue Dallas, 75246, TX
- Gender: Male
- Address: 1638 Owen Drive Fayetteville, 28304, NC
- Gender: Male
- Address: 1 Nolte Drive Kittanning, 16201, PA
- Gender: Female
- Address: 200 1st Street Southwest Rochester, 55905, MN
- Gender: Male
- Address: 1800 Orleans Street Baltimore, 21287, MD
- Gender: Male
- Address: 6210 East Oak Street Scottsdale, 85257, AZ
- Gender: Male
- Address: 10401 West Thunderbird Boulevard Sun City, 85351, AZ
- Gender: Female
- Address: 55 Fruit Street Boston, 2114, MA
Questions & Answers
Where can you meet with Dr. James Brinkworth?
Dr. James Brinkworth's office is located at 1000 North Lee Avenue in Oklahoma City, OK 73102.
What conditions does Dr. James Brinkworth treat?
Dr. James Brinkworth provides treatment for Benign Tumor, Cyst, Infarction, Skin Biopsy.
Does Dr. James Brinkworth accept patients with Medicare?
Yes, Dr. James Brinkworth accepts patients with Medicare.